AMMO, Inc. Sells Manufacturing Assets to Focus on E-Commerce via GunBroker.com

AMMO, Inc. Shifts Focus to E-Commerce with Strategic Asset Sale

AMMO, Inc. has announced a definitive agreement to sell its ammunition manufacturing assets to Olin Winchester, LLC, for $75 million. This transaction, unanimously approved by AMMO's Board of Directors, is the culmination of a thorough strategic review that involved independent advisors and engagement with multiple potential buyers. With the sale, AMMO aims to sharpen its focus on GunBroker.com, the largest online marketplace for firearms and related products. The decision reflects a growing trend in the e-commerce sector, as consumer preferences increasingly shift towards online purchasing of firearms and ammunition.

The sale encompasses AMMO's 185,000 square-foot production facility in Manitowoc, Wisconsin, which will enhance Olin Winchester's operational capabilities through economies of scale. Christos Tsentas, Chair of AMMO's M&A Committee, emphasizes that this transaction not only aligns with shareholder interests but also positions the company for long-term success. The expected completion of the deal in the second quarter of 2025 will lead to an anticipated rebranding process and a corporate name change for AMMO, marking a significant shift in its operational strategy.

As AMMO prepares for this transition, it continues to enhance customer experiences on GunBroker.com, having recently implemented upgrades to its checkout process and outdoor services. The move to divest manufacturing assets is strategically timed, allowing AMMO to bolster its cash reserves for further investments into its profitable e-commerce segment. The company’s future focus lies firmly in expanding its digital marketplace, which is poised for significant growth as demand increases in the online firearms market.

Supporting Workforce Development in Life Sciences

In a related development within the manufacturing sector, The Ritedose Corporation has partnered with Newberry College to introduce a new Pharmaceutical Manufacturing program set to launch in the summer of 2025. This initiative aims to address the skills gap in South Carolina's growing life sciences industry by equipping students with the necessary competencies for careers in biotechnology, pharmaceuticals, and healthcare.

By combining industry expertise with academic strengths, this program will offer a 30-hour bachelor's degree and feature courses tailored to meet the evolving needs of the pharmaceutical sector. The collaboration not only helps prepare students for future careers but also represents a significant investment in workforce development, aligning educational outcomes with industry demands.